Fresh off an IPO and launching a generic GLP-1, Apotex CEO Jeff Watson has even bigger plans
🤖 D.R.A.F.T. Summary
The former CFL offensive lineman is leading the pharma giant into an unprecedented period of opportunity
Outlets covering this story
The Globe and Mail
LEFT
Only one perspective covered this story — no diversity detected
Side-by-Side Outlet Comparison — Starter+
See how 1 outlets framed this story — bias by source, F.A.C.T. framing analysis, and verdict side by side.
Unlock with Starter →